Emergent BioSolutions Inc.
EBS
DELAYED 1 MONTH
32 insider filings · Latest: Jun 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 4 9:30 PM | Sujata Tyagi DayalDirector | Sale | 13,761 | $8.40 | $115.6K | 100,563(D) | View → |
| May 1, 2026 | May 4 9:30 PM | Donald W DegolyerDirector | Sale | 15,481 | $8.40 | $130.0K | 129,721(D) | View → |
| Apr 30, 2026 | May 4 9:29 PM | Keith KatkinDirector | Sale | 15,481 | $8.28 | $128.2K | 96,294(D) | View → |
| May 1, 2026 | May 4 9:28 PM | Kathryn C ZoonDirector | Sale | 17,202 | $8.40 | $144.5K | 79,941(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | May 4 9:30 PM | Sujata Tyagi DayalDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:30 PM | Donald W DegolyerDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:29 PM | Keith KatkinDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:29 PM | Marvin L WhiteDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:29 PM | John D Fowler JRDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:28 PM | Ronald RichardDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:28 PM | Kathryn C ZoonDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:27 PM | Neal Franklin FowlerDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:23 PM | Zsolt HarsanyiDirector, Chairman | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Feb 25, 2026 | Mar 6 1:50 PM | Richard S LindahlEVP, Chief Financial Officer | H | 20,321 | $61.01 | 0(D) | View → |
| May 7, 2025 | Mar 6 1:50 PM | Richard S LindahlEVP, Chief Financial Officer | H | 19,963 | $48.33 | 0(D) | View → |
| Mar 3, 2026 | Mar 6 2:40 AM | Joseph C PapaDirector, President and CEO | Grant/Award | 252,194 | $8.99 | 1,784,694(D) | View → |
| Mar 3, 2026 | Mar 6 2:21 AM | Simon C LowrySVP, R&D, CMO | Grant/Award | 44,834 | $8.99 | 147,833(D) | View → |
| Mar 3, 2026 | Mar 6 2:20 AM | William HartzelSVP, Bioservices | Grant/Award | 44,834 | $8.99 | 259,545(D) | View → |
| Mar 3, 2026 | Mar 6 2:19 AM | Jessica PerlSVP, General Counsel, Corp Sec | Grant/Award | 46,702 | $8.99 | 142,647(D) | View → |
| Mar 3, 2026 | Mar 6 2:08 AM | Paul Anthony WilliamsSVP, Products Business | Grant/Award | 44,834 | $8.99 | 254,948(D) | View → |
| Mar 3, 2026 | Mar 6 2:07 AM | Richard S LindahlEVP, Chief Financial Officer | Grant/Award | 72,856 | $8.99 | 557,346(D) | View → |
| Mar 3, 2026 | Mar 6 2:06 AM | Coleen GlessnerEVP, Quality & Ethics, and CPL | Grant/Award | 44,834 | $8.99 | 294,447(D) | View → |